Rubicon Organics, a licensed producer focused on cultivating and selling organic certified cannabis products, announced the removal of all conditions precedent, related to its previously announced purchase and sale agreement with MediPharm Labs for an operational 47,500-square-foot indoor cultivation facility in Hope, British Columbia.
This milestone clears the path for Rubicon Organics to finalize the acquisition of the Hope Facility, which is expected to significantly expand the company’s production capacity and support its growth strategy.
“Our acquisition of the Hope Facility marks a pivotal step forward, for Rubicon Organics,” said Margaret Brodie, Chief Executive Officer of Rubicon Organics. “The Hope Facility enhances our ability to meet growing demand for our premium brands, accelerate innovation, and drive long-term value for shareholders.”
The company expects to close the acquisition of the Hope Facility in the second quarter and will provide further updates as they become available.
